Citation Impact
Citing Papers
The Mechanism of Action of Antitumor Platinum Compounds
1979
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Prevention of cervical cancer through papillomavirus vaccination
2004
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Infections and immune factors in cancer: the role of epidemiology
2004
Epstein‐barr virus antibody patterns preceding the diagnosis of non‐hodgkin's lymphoma
1991
The epidemiology of human papillomavirus infections
2005
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process
2015
Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers
2000
Global Cancer Statistics, 2002
2005 Standout
Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
2012
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality
1990 StandoutNobel
Prevalence of HPV Infection Among Females in the United States
2007 Standout
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study
2005
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Human papillomavirus, herpes simplex virus and cervical cancer incidence in greenland and denmark. A population‐based cross‐sectional study
1988
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus–Like Particles in Human Immunodeficiency Virus (HIV)–Positive and High‐Risk HIV–Negative Women
2003
Human papillomavirus and cervical cancer
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Helicobacter pylori Infection and Gastric Lymphoma
1994 Standout
Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells
1990 StandoutNobel
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort
2004
Head and Neck Cancer
1993 Standout
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
1998 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence
1988
Oncogenic DNA viruses
2001 StandoutNobel
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
Serum Immunoglobulin G Response to Human Papillomavirus Type 16 Virus‐Like Particles in Human Immunodeficiency Virus (HIV)–Positive and Risk‐Matched HIV‐Negative Women
2003
Epstein--Barr Virus Gene Expression in Nasopharyngeal Carcinoma
1988
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells
1996
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma
2003
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
Epstein–Barr Virus Infection
2000 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Cis- and trans-diamminedichloroplatinum(II) binding produces different tertiary structural changes on SV40 DNA
1982
Risk factors for cervical neoplasia in Denmark
1998
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
1992
Improving Protein Expression, Stability, and Function with ProteinMPNN
2024 StandoutNobel
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.
2001
A research for the relationship between human papillomavirus and human uterine cervical carcinoma
1991
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.
1977 StandoutNobel
Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position.
1986 StandoutNobel
A research for the relationship between human papillomavirus and human uterine cervical carcinoma
1991
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells.
1991 StandoutNobel
Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.
1975 StandoutNobel
Human Papillomavirus and Prognosis of Invasive Cervical Cancer: A Population-Based Study
2001
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Epstein–Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements
1984 StandoutNatureNobel
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
1976 StandoutScience
Herpesviruses and Oncogenesis
1972
Molecular Characterization of Novel Reciprocal Translocation t(6;14) in an Epstein-Barr Virus-Transformed B Cell Precursor
1987 StandoutNobel
Role of the human papillomaviruses in human cancer.
1991
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G
1985
Epidemiology of uterine cervical cancer
1986
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
A millennium update on pediatric diarrheal illness in the developing world
2005
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Viruses in Human Cancers
1991 StandoutScienceNobel
Tumor initiators and promoters in the induction of Epstein—Barr virus
1979 StandoutNobel
Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
1992 StandoutNobel
Continuous Lymphoid Cell Lines with Characteristics of B Cells (Bone-Marrow-Derived), Lacking the Epstein-Barr Virus Genome and Derived from Three Human Lymphomas
1974 StandoutNobel
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer
1992
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
1977 StandoutNature
Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the Nasopharynx
1974 StandoutNobel
Replication of Epstein–Barr Virus within the Epithelial Cells of Oral Hairy Leukoplakia, an AIDS-Associated Lesion
1985
The Ability of Two Listeria monocytogenes Vaccines Targeting Human Papillomavirus-16 E7 to Induce an Antitumor Response Correlates with Myeloid Dendritic Cell Function
2004
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Causality in medicine: the case of tumours and viruses
2000
Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines
1973 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of V. Vonka being referenced
Inactivation of papovavirus SV 40 by cis-dichlorodiammine platinum(II).
1972
Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines
1970
Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro
1990
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
1997
Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles
1999
Procedure for refolding and purification of recombinant proteins from Escherichia coli inclusion bodies using a strong anion exchanger
1994
Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA
1990
Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant
1991
Presence of Epstein-Barr Virus DNA in Carcinomas of the Palatine Tonsil
1984
Prospective study on the relationship between cervical neoplasia and herpes simplex type‐2 virus. I. Epidemiological characteristics
1984
Demonstration of Epstein-Barr Virus in Malignant Non-Hodgkin’s Lymphomas
1986
Influence of cis-Dichlorodiammineplatinum (II) on Growth of SV 40 Virus in Green Monkey Kidney Cells
1972
Association of some supraglottic laryngeal carcinomas with EB virus
1983
Serological properties of antigenically different derivatives of LSc 2 ab poliovirus
1962
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
1999
Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide.
2001
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16
2001
Presence Of Antibodies To Seven Human Papillomavirus Type 16-Derived
1994
Prospective study on the relationship between cervical neoplasia and herpes simplex type‐2 virus. II. Herpes simplex type‐2 antibody presence in sera taken at enrolment
1984